Yayın: Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome
| dc.contributor.author | Aktaş, Nimet | |
| dc.contributor.buuauthor | Oruç, Ayşegül | |
| dc.contributor.buuauthor | Ayar, Yavuz | |
| dc.contributor.buuauthor | Vuruşkan, Berna Aytaç | |
| dc.contributor.buuauthor | Yıldız, Abdülmecit | |
| dc.contributor.buuauthor | Yavuz, Mahmut | |
| dc.contributor.buuauthor | Güllülü, Mustafa | |
| dc.contributor.buuauthor | Dilek, Kamil | |
| dc.contributor.buuauthor | Ersoy, Alparslan | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Patoloji Ana Bilim Dalı | |
| dc.contributor.department | İç Hastalıkları Ana Bilim Dalı | |
| dc.contributor.department | Nefroloji Ana Bilim Dalı | |
| dc.contributor.orcid | 0000-0002-0342-9692 | |
| dc.contributor.orcid | 0000-0003-4607-9220 | |
| dc.contributor.researcherid | AAH-4002-2021 | |
| dc.contributor.researcherid | O-9948-2015 | |
| dc.contributor.researcherid | AAH-9746-2021 | |
| dc.contributor.researcherid | AGF-0767-2022 | |
| dc.contributor.researcherid | GSE-0029-2022 | |
| dc.contributor.scopusid | 55133912100 | |
| dc.contributor.scopusid | 55860143300 | |
| dc.contributor.scopusid | 56527372000 | |
| dc.contributor.scopusid | 56256977500 | |
| dc.contributor.scopusid | 7006244754 | |
| dc.contributor.scopusid | 6602684544 | |
| dc.contributor.scopusid | 56005080200 | |
| dc.contributor.scopusid | 35612977100 | |
| dc.date.accessioned | 2023-11-09T06:21:49Z | |
| dc.date.available | 2023-11-09T06:21:49Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | Oruç, A. vd. (2018). ''Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome''. Nefrologia, 38(4), 448-450. | |
| dc.identifier.doi | 10.1016/j.nefroe.2018.04.004 | |
| dc.identifier.endpage | 450 | |
| dc.identifier.issn | 0211-6995 | |
| dc.identifier.issn | 1989-2284 | |
| dc.identifier.issue | 4 | |
| dc.identifier.pubmed | 29221881 | |
| dc.identifier.scopus | 2-s2.0-85049994526 | |
| dc.identifier.startpage | 448 | |
| dc.identifier.uri | https://doi.org/10.1016/j.nefroe.2018.04.004 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S2013251418300622 | |
| dc.identifier.uri | http://hdl.handle.net/11452/34810 | |
| dc.identifier.volume | 38 | |
| dc.identifier.wos | 000439099700019 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Soc Espanola Nefrologia Dr Rafael Matesanz | |
| dc.relation.collaboration | Sanayi | |
| dc.relation.journal | Nefrologia | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Urology & nephrology | |
| dc.subject | Complement inhibitor eculizumab | |
| dc.subject.emtree | Aminotransferase | |
| dc.subject.emtree | Amlodipine | |
| dc.subject.emtree | Carvedilol | |
| dc.subject.emtree | Creatinine | |
| dc.subject.emtree | Eculizumab | |
| dc.subject.emtree | Lactate dehydrogenase | |
| dc.subject.emtree | Methyldopa | |
| dc.subject.emtree | Ramipril | |
| dc.subject.emtree | Eculizumab | |
| dc.subject.emtree | Monoclonal antibody | |
| dc.subject.emtree | Adult | |
| dc.subject.emtree | Blood pressure regulation | |
| dc.subject.emtree | Blood smear | |
| dc.subject.emtree | Case report | |
| dc.subject.emtree | Clinical article | |
| dc.subject.emtree | Creatinine blood level | |
| dc.subject.emtree | Disease classification | |
| dc.subject.emtree | Drug withdrawal | |
| dc.subject.emtree | Echography | |
| dc.subject.emtree | Fatty liver | |
| dc.subject.emtree | Headache | |
| dc.subject.emtree | Hemolytic uremic syndrome | |
| dc.subject.emtree | Hepatomegaly | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Human cell | |
| dc.subject.emtree | Human tissue | |
| dc.subject.emtree | Hypertension retinopathy | |
| dc.subject.emtree | Kidney biopsy | |
| dc.subject.emtree | Laboratory test | |
| dc.subject.emtree | Lactate dehydrogenase blood level | |
| dc.subject.emtree | Letter | |
| dc.subject.emtree | Liver toxicity | |
| dc.subject.emtree | Male | |
| dc.subject.emtree | Physical examination | |
| dc.subject.emtree | Plasma exchange | |
| dc.subject.emtree | Thrombocytopenia | |
| dc.subject.emtree | Thrombotic thrombocytopenic purpura | |
| dc.subject.emtree | Treatment duration | |
| dc.subject.emtree | Complication | |
| dc.subject.emtree | Hemolytic uremic syndrome | |
| dc.subject.emtree | Toxic hepatitis | |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Antibodies, monoclonal, humanized | |
| dc.subject.mesh | Atypical hemolytic uremic syndrome | |
| dc.subject.mesh | Chemical and drug induced liver injury | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Male | |
| dc.subject.wos | Urology & nephrology | |
| dc.title | Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome | |
| dc.title.alternative | Hepatotoxicidad asociada con eculizumab en un paciente con síndrome urémico hemolítico atípico | |
| dc.type | Letter | |
| dc.wos.quartile | Q4 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/İç Hastalıkları Ana Bilim Dalı/Nefroloji Ana Bilim Dalı | |
| local.contributor.department | Tıp Fakültesi/Patoloji Ana Bilim Dalı | |
| local.indexed.at | Scopus | |
| local.indexed.at | WOS |
